Obeda in India

What is Obeda?

Obeda is a brand of semaglutide, a medicine that belongs to a class called GLP-1 receptor agonists. GLP-1 (glucagon-like peptide-1) is a natural hormone your body releases after eating that helps control blood sugar and signals fullness to the brain. Semaglutide mimics this hormone.

In India, semaglutide is typically prescribed for:

• Type 2 diabetes — to help lower blood sugar (HbA1c), often alongside other diabetes medicines such as metformin.
• Chronic weight management — for adults with obesity, or with overweight plus weight-related health conditions, when combined with diet and physical activity.

Your doctor will confirm whether Obeda is appropriate for your specific situation.

How is it taken?

Obeda is given as a once-weekly injection under the skin (subcutaneous) — usually in the abdomen, thigh, or upper arm. It is not a daily tablet. The injection is self-administered using a pre-filled pen on the same day each week, with or without food.

Who is it typically prescribed for in India?

Indian doctors commonly consider semaglutide for adults whose blood sugar is not well controlled on oral medicines alone, or for adults managing obesity under medical supervision. It is not used in type 1 diabetes and is not a first-line medicine for everyone — suitability depends on your medical history, kidney function, and other factors.

Always consult your doctor before starting or changing any GLP-1 medication.

Who makes Obeda?

Obeda is manufactured and marketed in India by Dr Reddy's Laboratories, one of India's largest pharmaceutical companies, headquartered in Hyderabad.

Regulatory status

Obeda is approved by the Central Drugs Standard Control Organisation (CDSCO), India's national drug regulator, for use in eligible adults as determined by a prescribing doctor. It is a prescription-only medicine and should be dispensed by a licensed pharmacist against a valid prescription.

Brand status — generic of semaglutide

Obeda is a Dr Reddy's Laboratories generic version of semaglutide. Semaglutide as a molecule was originally developed and launched globally by a different originator company. Obeda is not the originator brand; it is an Indian generic of the same active ingredient, made available under Dr Reddy's own brand name.

This page does not carry any manufacturer endorsement and is for patient information only.

Typical titration schedule

Semaglutide is started low and increased slowly to help your body adjust and to reduce side effects like nausea. The pattern below is the typical schedule doctors follow — your own plan may differ.

• Weeks 1–4: 0.25 mg once weekly (starting dose; this dose is for getting used to the medicine, not for blood-sugar or weight effect).
• Weeks 5–8: 0.5 mg once weekly.
• From week 9 onwards: dose may be increased further (commonly to 1 mg weekly) if needed and tolerated.
• Higher maintenance doses (such as 1.7 mg or 2.4 mg weekly) are sometimes used, particularly for chronic weight management, again only after step-wise escalation.

Each step is usually held for at least 4 weeks before going up. If side effects appear, your doctor may pause the escalation, stay at the current dose longer, or step down temporarily.

The injection is taken on the same day each week, at any time of day, with or without food. If a dose is missed, there are specific rules about when to take or skip it — ask your doctor or pharmacist.

Your prescribing doctor will set your exact dose based on your response and any side effects.

Common side effects

Most people on semaglutide experience some side effects, especially in the first few weeks or after a dose increase. These are usually mild to moderate and improve over time as your body adjusts.

The most commonly reported effects include:

• Nausea — the most common; often strongest in the first days after a dose increase.
• Decreased appetite and feeling full sooner than usual.
• Vomiting.
• Diarrhoea or, in some people, constipation.
• Bloating, burping, or acidity-like discomfort.
• Tiredness or mild dizziness.
• Mild injection-site reactions — redness or itching where the injection was given.
• Headache.

Many people find that eating smaller portions, avoiding very oily or very heavy meals, and staying well hydrated makes these symptoms more manageable — but any specific changes to your routine should be discussed with your doctor.

When to seek medical help

Contact your doctor immediately if you experience: severe or persistent abdominal pain (especially pain that spreads to your back, which can be a sign of pancreatitis); persistent vomiting or signs of dehydration; signs of an allergic reaction such as swelling of the face, lips, tongue or throat, rash, or difficulty breathing; sudden vision changes; symptoms of very low blood sugar (sweating, shakiness, confusion) — more likely if you also take insulin or sulfonylureas; signs of gallbladder problems such as upper-right abdominal pain, yellowing of the skin or eyes, or fever.

Do not stop or change your dose without medical advice.